NIVESTYM DESIGN

View On IC.GC.CA

REGISTERED

on 23 Aug 2024

Last Applicant/ Owned by

PFIZER LIMITED

Ramsgate RoadSandwichKent,

Serial Number

1980174 filed on 12^th Aug 2019

Registration Number

TMA1251846 registered on 23^rd Aug 2024

Registration expiry Date

23^rd Aug 2034

Correspondent Address

MBM INTELLECTUAL PROPERTY AGENCY

275 SLATER STREET14TH FLOOROTTAWA

ONTARIO

K1P5H9

NIVESTYM DESIGN

Trademark usage description

pharmaceutical preparations used for stimulating white blood cell production for the treatment of neutropenia and neutropenia-related clinical conditi Read More

Vienna Information

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

26 . 11 . 2

Two lines or bandsDeux lignes ou bandes

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

26 . 4 . 2

RectanglesRectangles

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 11

Quadrilaterals containing one or more triangles or lines forming an angleQuadrilatères contenant un ou plusieurs triangles ou des lignes formant un angle

26 . 4 . 18

Quadrilaterals containing one or more lettersQuadrilatères contenant une ou plusieurs lettres

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

29 . 1 . 3

GreenVert

29 . 1 . 4

BlueBleu

29 . 1 . 8

BlackNoir

Classification Information

Class [005]
Pharmaceutical preparations used for stimulating white blood cell production for the treatment of neutropenia and neutropenia-related clinical conditions, for the treatment of hematopoietic syndrome, and for patients undergoing autologous peripheral blood progenitor cell collection and therapy

Classification kind code

Mark Details

Serial Number

1980174

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 5^th Jun 2024	Advertised
Submitted for opposition 27 on 7^th May 2024	Approval Notice Sent
Submitted for opposition 26 on 7^th May 2024	Approved
Submitted for opposition 22 on 15^th Apr 2024	Search Recorded
Submitted for opposition 20 on 15^th Apr 2024	Examiner's First Report
Submitted for opposition 67 on 30^th Dec 2022	Agent Name Changed
Submitted for opposition 287 on 2^th Jun 2022	Pre-Assessment Letter Sent
Submitted for opposition 31 on 15^th Aug 2019	Formalized
Submitted for opposition 1 on 13^th Aug 2019	Created
Submitted for opposition 30 on 12^th Aug 2019	Filed